Concepedia

Author

Agnes Leffler

AstraZeneca (Sweden)

Also Known As

A. Leffler, A.E. Leffler, Agnes Leffler, Leffler, A. E.

10

Publications

189

Citations

6

H-Index

17

Concepts

All Affiliations

AstraZeneca (Sweden)
AL

About

Agnes Leffler is an author at AstraZeneca (Sweden) specializing in medicine, molecular pharmacology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

104

2

Immunology

3

3

67

3

Natural Sciences

1

1

37

4

Biochemistry

1

1

37

5

Chemical Biology

1

1

37

Agnes Leffler

×

6

Publications

189

Citations

6

H-Index

YearCitations

Benzoxazepines Achieve Potent Suppression of IL‐17 Release in Human T‐Helper 17 (T<sub>H</sub>17) Cells through an Induced‐Fit Binding Mode to the Nuclear Receptor RORγ

Roine I. Olsson, Yafeng Xue, Stefan von Berg,

ChemMedChem

2015

61

Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3

Agnes Leffler, Ingela Ahlstedt, Susanna Engberg,

Biochemical Pharmacology

2009

38

Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design

Frank Narjes, Yafeng Xue, Stefan von Berg,

Journal of Medicinal Chemistry

2018

37

AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2

Frank Narjes, Antonio Llinàs, Stefan von Berg,

Journal of Medicinal Chemistry

2021

24

Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors

Susanna Engberg, Ingela Ahlstedt, Agnes Leffler,

Biochemical Pharmacology

2006

18

Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists

Monika Sundqvist, Elin Kristensson, Agnes Leffler,

European Journal of Pharmacology

2007

11

Page 1